mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.3 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |